Melola Discovery

← Melola Discovery

Jurnal SINTA 1

In Silico Study, Design, and Expression of an Intranasal Dual Chimeric Vaccine for Indonesian-Based Norovirus GII-2 and Hepatitis B

HAYATI Journal of Biosciences · Vol. 31 No. 5 (2024) · hlm. 1007–1018

DOI
10.4308/hjb.31.5.1007-1018
ISSN
2086-4094, 1978-3019
Terbit
2024-07-03
Penerbit
Bogor Agricultural University, Indonesia
Bahasa
eng

Abstrak

Hepatitis B virus (HBV) remains an important healthcare challenge, leading to liver diseases like cirrhosis and cancer. In response, we created a prophylactic and therapeutic HBV vaccine by integrating HBcAg and HBsAg from HBV genotype B into Norovirus (NoV) GII.2 P domain (PdomGII.2-HBV) for enhanced intranasal delivery. This vaccine also aimed to simultaneously prevent NoV infection, which causes gastroenteritis. Since the selected HBV epitopes have undergone extensive research and are tailored to the Indonesian population, this study focused on identifying NoV epitopes and assessing T cell epitopes coverage of the PdomGII.2-HBV for the Indonesian population. Following that, we expressed the PdomGII.2-HBV protein using Escherichia coli BL21(DE3) and employed a gentle solubilization technique for protein purification. Our in-silico analysis identified two B cell epitopes, along with 15 CD4+T cell epitopes and 35 CD8+T cell epitopes within the GII.2 P domain. These T cell epitopes cover 100% of the Javanese-Sundanese population's HLA allele variations, which constituted the largest demographic group in Indonesia. Subsequently, we successfully purified the presumed PdomGII.2-HBV protein, revealing a molecular weight of 39.5 kDa. Following the successful expression and purification of the presumed PdomGII.2-HBV protein, it is evident that this vaccine design has significant potential, warranting further study.

Jaringan kolaborasi para penulis

40 penulis · 200 tautan kepenulisan bersama · 92 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Bandung Institute of Technology
  • National Research and Innovation Agency
  • Indonesian Institute of Sciences
  • National Nuclear Energy Agency of Indonesia
  • PT Bio Farma (Indonesia)
  • Universitas Gadjah Mada
  • Atma Jaya Catholic University of Indonesia
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Dessy NataliaBandung Institute of Technology3
Enny RatnaningsihBandung Institute of Technology2
Hariyatun HariyatunIndonesian Institute of Sciences2
Yana RubiyanaNational Research and Innovation Agency2
Popi Hadi WisnuwardhaniNational Research and Innovation Agency2
Ratih Asmana NingrumNational Research and Innovation Agency2
Fitri Aulia PermatasariBandung Institute of Technology2
Ferry IskandarBandung Institute of Technology2
Dian Fitria AgustiyantiNational Research and Innovation Agency2
Marissa AngelinaNational Research and Innovation Agency2
Andri WardianaNational Research and Innovation Agency2
Azzania FibrianiBandung Institute of Technology2
Patricia Gita NaullyBandung Institute of Technology2
Neni NurainyPT Bio Farma (Indonesia)2
Elvi RestiawatyBandung Institute of Technology2
Wardono NiloperbowoBandung Institute of Technology2
Anita ArtariniBandung Institute of Technology2
Heni RachmawatiBandung Institute of Technology1
Isti DaruwatiNational Nuclear Energy Agency of Indonesia1
Aang Hanafiah WangsaatmadjaNational Nuclear Energy Agency of Indonesia1
Zuhdina SabiqohBandung Institute of Technology1
Raymond R. TjandrawinataAtma Jaya Catholic University of Indonesia1
Armini SyamsidiBandung Institute of Technology1
Anindyajati AnindyajatiUniversitas Gadjah Mada1
AnindyajatiAfiliasi tidak diketahui1
Catur RianiBandung Institute of Technology1
Ernawati Arifin Giri-RachmanBandung Institute of Technology1
Salma Aulia AfifahBandung Institute of Technology1
Desriani DesrianiIndonesian Institute of Sciences1
Audrey Angelina Putri TaharuddinBandung Institute of Technology1
Nicholas YamahokiBandung Institute of Technology1
Rebecca StephanieBandung Institute of Technology1
Nahdiya Laila MufidaBandung Institute of Technology1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://journal.ipb.ac.id/index.php/hayati/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">In Silico Study, Design, and Expression of an Intranasal Dual Chimeric Vaccine for Indonesian-Based Norovirus GII-2 and Hepatitis B</dc:title>
	<dc:creator xml:lang="en">Giri-Rachman, Ernawati Arifin</dc:creator>
	<dc:creator xml:lang="en">Tan, Marselina Irasonia </dc:creator>
	<dc:creator xml:lang="en">Novia Syari Intan</dc:creator>
	<dc:creator xml:lang="en">Putri Ayu Fajar</dc:creator>
	<dc:creator xml:lang="en">Wojciechowska, Gladys Emmanuella Putri</dc:creator>
	<dc:creator xml:lang="en">Hertadi, Rukman</dc:creator>
	<dc:creator xml:lang="en">Retnoningrum, Debbie Soefie</dc:creator>
	<dc:description xml:lang="en">Hepatitis B virus (HBV) remains an important healthcare challenge, leading to liver diseases like cirrhosis and cancer. In response, we created a prophylactic and therapeutic HBV vaccine by integrating HBcAg and HBsAg from HBV genotype B into Norovirus (NoV) GII.2 P domain (PdomGII.2-HBV) for enhanced intranasal delivery. This vaccine also aimed to simultaneously prevent NoV infection, which causes gastroenteritis. Since the selected HBV epitopes have undergone extensive research and are tailored to the Indonesian population, this study focused on identifying NoV epitopes and assessing T cell epitopes coverage of the PdomGII.2-HBV for the Indonesian population. Following that, we expressed the PdomGII.2-HBV protein using Escherichia coli BL21(DE3) and employed a gentle solubilization technique for protein purification. Our in-silico analysis identified two B cell epitopes, along with 15 CD4+T cell epitopes and 35 CD8+T cell epitopes within the GII.2 P domain. These T cell epitopes cover 100% of the Javanese-Sundanese population's HLA allele variations, which constituted the largest demographic group in Indonesia. Subsequently, we successfully purified the presumed PdomGII.2-HBV protein, revealing a molecular weight of 39.5 kDa. Following the successful expression and purification of the presumed PdomGII.2-HBV protein, it is evident that this vaccine design has significant potential, warranting further study.</dc:description>
	<dc:publisher xml:lang="en">Bogor Agricultural University, Indonesia</dc:publisher>
	<dc:date>2024-07-03</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://journal.ipb.ac.id/hayati/article/view/51565</dc:identifier>
	<dc:identifier>10.4308/hjb.31.5.1007-1018</dc:identifier>
	<dc:source xml:lang="en">HAYATI Journal of Biosciences; Vol. 31 No. 5 (2024): September 2024; 1007-1018</dc:source>
	<dc:source>2086-4094</dc:source>
	<dc:source>1978-3019</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://journal.ipb.ac.id/hayati/article/view/51565/28560</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Ernawati Arifin Giri-Rachman, Marselina Irasonia  Tan, Novia Syari Intan, Putri Ayu Fajar, Gladys Emmanuella Putri Wojciechowska, Rukman Hertadi, Debbie Soefie Retnoningrum</dc:rights>
</oai_dc:dc>